Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.49
12.12.21
-
12.12.22
4.74%
25.12.21

Could be worthwhile Investment >10% per year
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.48
12.12.21
-
12.12.22
25.48%
25.12.21

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.66
12.12.21
-
12.12.22
-1.27%
25.12.21

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
11.12.21
€30.00
11.12.22
8.73%
25.12.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Epizyme Inc.

Start price
Target price
Perf. (%)
€2.63
11.12.21
-
11.12.22
-45.63%
08.12.22

Probably not worthwhile Investment
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.24
11.12.21
-
11.12.22
-16.73%
08.12.22

Risky Investment
buy
Vitesco Technologies Group AG

Start price
Target price
Perf. (%)
€45.15
09.12.21
€50.00
09.12.22
-1.93%
10.07.22

Could be worthwhile Investment >10% per year
buy
Digital Turbine Inc.

Start price
Target price
Perf. (%)
€51.06
09.12.21
€60.00
09.12.22
-69.73%
10.12.22

Could be worthwhile Investment >10% per year
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€7.05
08.12.21
-
08.12.22
-4.99%
12.12.21

Risky Investment
buy
Pierre & Vacances S.A.

Start price
Target price
Perf. (%)
€6.78
07.12.21
€10.00
07.12.22
4.13%
22.01.22

Could be worthwhile Investment >10% per year
buy
Aldeyra Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.90
07.12.21
-
07.12.22
4.24%
11.12.21

Risky Investment
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€29.24
06.12.21
€40.00
06.12.22
-54.08%
07.12.22

Could be worthwhile Investment >10% per year
buy
GFT Technologies AG

Start price
Target price
Perf. (%)
€39.45
06.12.21
€43.50
06.12.22
-12.29%
07.12.22

Could be worthwhile Investment >10% per year
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€3.87
05.12.21
€1.90
05.12.22
-24.28%
16.03.22

Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
Baozun Inc ADR

Start price
Target price
Perf. (%)
€11.75
05.12.21
€4.00
05.12.22
-40.26%
16.03.22

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Nordex SE

Start price
Target price
Perf. (%)
€14.95
05.12.21
-
05.12.22
-5.42%
23.12.21

buy
Nordex SE

Start price
Target price
Perf. (%)
€14.95
05.12.21
-
05.12.22
-5.42%
23.12.21

buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€13.05
05.12.21
-
05.12.22
-48.66%
11.12.21

Risky Investment
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.88
05.12.21
-
05.12.22
0.47%
12.12.21

Risky Investment
buy
Dürr AG

Start price
Target price
Perf. (%)
€37.44
05.12.21
€44.00
05.12.22
-11.32%
06.12.22

Could be worthwhile Investment >10% per year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€147.98
05.12.21
-
05.12.22
-23.17%
07.01.22

Could be worthwhile Investment >10% per year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.42
03.12.21
-
03.12.22
7.50%
11.12.21

Risky Investment
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.62
03.12.21
-
03.12.22
0.84%
11.12.21

Could be worthwhile Investment >10% per year
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.28
02.12.21
-
02.12.22
-0.61%
11.12.21

Risky Investment
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€4.85
01.12.21
-
01.12.22
-53.67%
02.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model